Linda M. Rubinstein

Chief Financial Officer, Solexa, Inc.

Companies

Nektar TherapeuticsChief financial officer May 26, 2026 to now¹
Avalanche BiotechnologiesChief financial officer Dec 15, 2022 to now²
BIOCEPT INCBoard member Jul 20, 2021 to Sep 8, 2022³
Alector (United States)Chief financial officer Sep 9, 2021 to Sep 9, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Avalanche Biotechnologies ADVM0 shares⁵Dec 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 9, 2025U 42,000 shares of Avalanche Biotechnologies⁵
Dec 9, 2025Granted 42,000 shares of Avalanche Biotechnologies⁵
Dec 9, 2025U 8,125 shares of Avalanche Biotechnologies⁵
Dec 9, 2025U 61,150 shares of Avalanche Biotechnologies⁵
Dec 9, 2025Exercised options 48,750 shares at $4.20 of Avalanche Biotechnologies⁵
Feb 25, 2025Granted 8,125 shares of Avalanche Biotechnologies⁶
Jun 7, 2023Bought 100,000 shares at $1.45 of Avalanche Biotechnologies⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNektar Therapeutics, Chief financial officer
2
SEC EDGARAvalanche Biotechnologies, Chief financial officer
3
SEC EDGARBIOCEPT INC, Board member
4
SEC EDGARAlector (United States), Chief financial officer
5
SEC EDGARAvalanche Biotechnologies shares after the filing of Dec 9, 2025
6
SEC EDGARForm 4 filed Feb 27, 2025
7
SEC EDGARForm 4 filed Jun 9, 2023